Furia John P, Rompe Jan-Dirk, Maffulli Nicola, Cacchio Angelo, Schmitz Christoph
*SUN Orthopaedics and Sports Medicine, Division of Evangelical Community Hospital, Lewisburg, Pennsylvania; †OrthoTrauma Evaluation Institute, Mainz, Germany; ‡Centre for Sports and Excercise Medicine, Mile End Hospital, Queen Mary University of London, London, United Kingdom; §Department of Life, Health and Environmental Sciences, School of Medicine, University of L'Aquila, L'Aquila, Italy; and ¶Extracorporeal Shock Wave Research Unit, Department of Anatomy II, Ludwig-Maximilians-University of Munich, Munich, Germany.
Clin J Sport Med. 2017 Sep;27(5):430-437. doi: 10.1097/JSM.0000000000000399.
To assess the efficacy and safety of radial extracorporeal shock wave therapy (rESWT) for chronic distal biceps tendinopathy (cDBT).
Case-control study (level of evidence, 3).
SUN Orthopaedics and Sports Medicine.
Patients with a diagnosis of cDBT were recruited between January 2010 and February 2015.
Patients received a single session of rESWT (2000 shock waves with energy flux density of 0.18 mJ/mm) or other forms of nonoperative therapy.
Patients completed the visual analog scale (VAS), the modified QuickDASH (MQD) score, and the Roles and Maudsley (RM) score over a 12-month period.
Forty-eight patients completed the final review at 12 months and were included in the study. Subjects ranged in age from 30 to 64 years. Mean pretreatment VAS scores for the rESWT and control groups were 8.3 and 8.5, respectively. Three and 12 months after inclusion in the study, the mean VAS scores for the rESWT and control groups were 3.4 and 5.6 (P < 0.001) and 2.7 and 4.7 (P < 0.001), respectively. Twelve-month follow-up MQD-Sports and MQD-Work scores for the rESWT and control groups were 3.7 and 1.7 (P < 0.001) and 3.8 and 1.8 (P < 0.001), respectively. Differences in mean RM scores were statistically significant between groups at 3 months after the treatment. There were no significant complications.
Overall, rESWT is an effective and safe treatment for cDBT.
Radial ESWT as a novel, effective, and safe treatment for cDBT.
评估桡侧体外冲击波疗法(rESWT)治疗慢性肱二头肌远端肌腱病(cDBT)的疗效和安全性。
病例对照研究(证据级别,3级)。
阳光骨科与运动医学中心。
2010年1月至2015年2月期间招募的确诊为cDBT的患者。
患者接受单次rESWT治疗(2000次冲击波,能量通量密度为0.18 mJ/mm²)或其他形式的非手术治疗。
患者在12个月内完成视觉模拟量表(VAS)、改良的QuickDASH(MQD)评分以及Roles和Maudsley(RM)评分。
48例患者在12个月时完成了最终评估并纳入研究。受试者年龄在30至64岁之间。rESWT组和对照组治疗前的平均VAS评分分别为8.3和8.5。纳入研究后3个月和12个月,rESWT组和对照组的平均VAS评分分别为3.4和5.6(P < 0.001)以及2.7和4.7(P < 0.001)。rESWT组和对照组12个月随访时的MQD-运动和MQD-工作评分分别为3.7和1.7(P < 0.001)以及3.8和1.8(P < 0.001)。治疗后3个月,两组间平均RM评分差异有统计学意义。未出现明显并发症。
总体而言,rESWT是治疗cDBT的一种有效且安全的方法。
桡侧ESWT是一种治疗cDBT的新型、有效且安全的方法。